Artemis Medicare Services Limited (ARTEMISMED.NS)
- Previous Close
277.00 - Open
276.20 - Bid --
- Ask --
- Day's Range
263.00 - 278.40 - 52 Week Range
143.05 - 350.00 - Volume
98,441 - Avg. Volume
135,510 - Market Cap (intraday)
-- - Beta (5Y Monthly) 0.34
- PE Ratio (TTM)
116.55 - EPS (TTM)
2.29 - Earnings Date May 8, 2025 - May 12, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
395.00
Artemis Medicare Services Limited engages in the management and operation of multi specialty hospitals in India and internationally. The company offers medical and surgical intervention; and inpatient and outpatient services. It also operates Artemis Hospital, a multi-specialty hospital located in Gurugram. In addition, the company provides billing and insurance, care pages, child care, emotional and support programs, health services, international patient services, medical interpreter and records services, mind body medicine, nursing, nutrition, patient and family advisory, patient advocacy and portal, pre-admission testing, and smoking cessation programs services; and executive Health Checks workplace clinics for counseling; outpatient and hospitalization services; healthcare education and awareness programs; first aid and BLS training; emergency services; and organizational healthcare audit services. Artemis Medicare Services Limited was incorporated in 2004 and is based in Gurugram, India.
www.artemishospitals.com1,991
Full Time Employees
March 31
Fiscal Year Ends
--
Sector
--
Industry
Recent News: ARTEMISMED.NS
View MorePerformance Overview: ARTEMISMED.NS
Trailing total returns as of 4/28/2025, which may include dividends or other distributions. Benchmark is MSCI WORLD (^990100-USD-STRD) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ARTEMISMED.NS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ARTEMISMED.NS
View MoreValuation Measures
Market Cap
--
Enterprise Value
--
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
8.00%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
9.22B
Net Income Avi to Common (ttm)
737.76M
Diluted EPS (ttm)
2.29
Balance Sheet and Cash Flow
Total Cash (mrq)
3.75B
Total Debt/Equity (mrq)
40.12%
Levered Free Cash Flow (ttm)
--